home / stock / bpts / bpts news

BPTS News and Press, Biophytis SA From 09/07/22

Stock Information
Company Name: Biophytis SA
Stock Symbol: BPTS
Market: NASDAQ
Menu
BPTS BPTS Quote BPTS Short BPTS News BPTS Articles BPTS Message Board
Get BPTS Alerts

News, Short Squeeze, Breakout and More Instantly...
BPTS - Biophytis Announces Very Promising Top Line Results of its Phase 2-3 COVA Clinical Study in COVID-19-Related Respiratory Failure

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / September 7th, 2022 / Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated wit...
BPTS - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com We’re starting off Tuesday with a breakdown of the biggest pre-market stock movers traders need to know about! Moving stocks this morning are earnings reports, heavy trading ...

BPTS - Biophytis Announces the Drawing of the Second Tranche of Ornane Under the 2021 Atlas Contract for Euro4 Million

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 30, 2022 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, including severe respirator...

BPTS - Biophytis Presents the Development of Sarconeos (BIO101) in Phase 3 for the Treatment of Sarcopenia at the 15th SCWD International Congress

PARIS, FRANCE and CAMBRIDGE, MASSACHUSETTS / ACCESSWIRE / June 27, 2022 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS) , ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associat...
BPTS - Biophytis: Results of the Combined General Meeting on June 21, 2022

All ordinary and extraordinary resolutions presented by the company have been adopted PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 22, 2022 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), (Biophytis or the company), a clinical-stage biotechnology company focused on ...

BPTS - BTCM, ANTE and CLNN among mid-day movers

Gainers: Day One Biopharmaceuticals (DAWN) +103%. Redbox Entertainment (RDBXW) +85%. OptiNose (OPTN) +37%. Cerberus Cyber Sentinel Corporation (CISO) +36%. Ekso Bionics Holdings (EKSO) +35%. AeroClean Technologies (AERC) +33%. Redbox Entertainment (RDBX) +29%. Electro-Sensors (ELSE) +17%. Cyn...

BPTS - Biophytis: Convening of Another Combined General Meeting at a Later Date

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 3, 2022 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with agin...
BPTS - Biophytis: Biophytis Announces its Participation at the BIO International Convention in San Diego from the 13th to the 16th of June

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / May 12, 2022 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging,...

BPTS - RBLX, CVM and ATER among mid-day movers

Gainers: Clarus Therapeutics Holdings (CRXT) +87%. Winc (WBEV) +27%. AlloVir (ALVR) +26%. NexImmune (NEXI) +24%. Charah Solutions (CHRA) +22%. Target Hospitality (TH) +20%. Phio Pharmaceuticals (PHIO) +20%. Healthcare Services Group (HCSG) +19%. CEL-SCI (CVM) +18%. Biophytis (BPTS) +17%. Lose...

BPTS - AlloVir, Biophytis top healthcare gainers; while Arcturus, Diffusion lead losers' pack

Gainers: AlloVir (ALVR) +41%. Biophytis (BPTS) +22%. Clarus Therapeutics (CRXT) +22%. Healthcare Services (HCSG) +20%. BioSig Technologies (BSGM) +6%. Losers: Arcturus Therapeutics (ARCT) -22%. Diffusion Pharmaceuticals (DFFN) -13%. Seer (SEER) -7%. HTG Molecular...
Previous 10 Next 10